Search CommunityWalk:
Create_a_map_small
Mymaps_small



Blank

BioFactura, Inc.

Address:
9430 Key West Ave, #125
--
Rockville, MD 20850, USA
1-301-315-8002

Category: Biotechnology/Biopharmaceutical

Used in the following map:

Maryland Biotech Industry Map

BioFactura Inc is a biopharmaceutical development offers companies developing monoclonal antibody-based drugs shorter time-to-market, reduced costs, and high potency/fidelity drug candidates through the application of its proprietary Rapid Human Antibody Generation or RHAGe System. The company utilizes its expertise in bio-manufacturing to develop technologies that adds value to therapeutics as they progress from discovery through clinical trials and into the market.

BioFactura's Rapid Human Antibody Generation or RHAGe is an end-to-end system for the discovery and commercialization of fully-human monoclonal antibody (mAb) drug candidates. Its VeriCyte Discovery Platform isolates fully human therapeutic mAbs from human B lymphocytes. The Company's StableFast Biomanufacturing Platform, which utilizes the FDA-approved NS0 cell line, and allows the rapid development and production of lead mAb candidates. Its RHAGe drug development system offers companies developing monoclonal antibody-based drugs shorter time-to-market, reduced costs, and high potency and fidelity drug candidates. It also offers contract services such as: Stable Cell Lines - StableFast-NS0 Cell Line, CHO DG44 Cell Line; Bioprocess Development; and Biologics Manufacturing.

BioFactura is committed to identifying and fulfilling unmet national biodefense and biomedical needs. The company is focused on bringing a drug for the treatment of smallpox and adverse smallpox vaccination events in collaboration with the U.S. Army and Department of Defense.

BioFactura's partners include: University of Maryland, USAMRIID, Sequella, Inc, Capital Genomix Inc, BioAssay, etc.